A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT05421078
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT05421078
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT05421078. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-27 (actual); primary completion 2023-03-24 (actual). Results posted on 2024-09-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.
- Condition
- Dyslipidemia
- Condition
- Hypercholesterolemia
- Condition
- High Cholesterol
- Intervention (Drug)
- Obicetrapib
- Intervention (Drug)
- Placebo
- Lead sponsor
- NewAmsterdam Pharma
Record details
- Record id
cardio:ct-nct05421078- Content hash
2ed989c1c959a055d87fa6eedf55dedc61cefc2e39313b86e6d2252944a25608